Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Chuangyuan Biotechnology is a synthetic biology company specializing in the microbial production of high-value natural products and pharmaceutical intermediates. The company utilizes advanced metabolic engineering and fermentation technologies to develop microbial cell factories that produce carotenoids, such as astaxanthin and lycopene, as well as other bio-based chemicals like 5-HTP. Their approach provides a sustainable and efficient alternative to traditional chemical synthesis and plant-based extraction methods. Headquartered in Tianjin, China, the company serves the global nutrition, healthcare, and animal feed markets with high-purity ingredients. Tianjin Chuangyuan is recognized for its integration of academic research into industrial-scale bio-manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Chuangyuan Biotechnology.